58 Group

58 Biotec, officially known as Beijing 58 Biotec Co., Ltd., is a Chinese biotechnology company specializing in the research, development, and commercialization of human vaccines. The company is most recognized for its human rabies vaccine produced using Vero cell technology, which is widely utilized in the Chinese market. Beyond rabies, 58 Biotec maintains a pipeline focused on infectious diseases, including candidates for varicella and influenza. The company operates large-scale manufacturing facilities that adhere to Good Manufacturing Practice (GMP) standards to support its commercial and clinical programs. 58 Biotec plays a significant role in the domestic vaccine supply chain in China, focusing on high-demand biologics for public health.